Avadim Adamant Its Support For Homeopathic Topical Ad Claims Meets FTC Standards
Two Reviews By Industry Self-Regulation Group Fault Avadim’s Supporting Evidence
Executive Summary
Avadim Health could get FTC scrutiny after it declines to comply with two findings by an industry self-regulation group to discontinue 26 claims for its Theraworx Relief homeopathic products. It says the analysis “misapplied the well-recognized standards of substantiation” established by FTC.